Originally a research scientist, Richard gained his PhD in Molecular Microbiology from Aston University before qualifying as a Chartered Accountant in 2015. Post qualification he has held roles in a global management consulting business and most recently, at Vaccitech (co-inventor of Vaxzevria, OU/AZ Covid-19 vaccine). In addition to managing the finance team he worked alongside senior leaders to successfully list Vaccitech on the US stock market in 2021.